InvestSMART

PainChek Ltd (ASX: PCK) - Announcements

Current share price for PCK : $0.078 0.008 (11.43%)+

ASX company news and announcements for PainChek Ltd (PCK) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All PainChek Ltd (PCK) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than PainChek Ltd (PCK), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for PainChek Ltd (PCK)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$16 Corporate Governance Statement & Appendix 4G 2023 29 Sep 2023 9:24AM $0.042 $0.078 risen by 85.71%
$16 Financial Report for the year ended 30 June 2023 29 Sep 2023 9:12AM $0.042 $0.078 risen by 85.71%
$16 Cleansing Notice 27 Sep 2023 10:04AM $0.042 $0.078 risen by 85.71%
$16 Application for quotation of securities - PCK 27 Sep 2023 10:01AM $0.042 $0.078 risen by 85.71%
$16 Response to ASX Price Query 21 Sep 2023 2:49PM $0.043 $0.078 risen by 81.40%
$16 Cleansing Notice 20 Sep 2023 1:51PM $0.030 $0.078 risen by 160%
$16 Application for quotation of securities - PCK 20 Sep 2023 9:36AM $0.029 $0.078 risen by 168.97%
$16 Update - Proposed issue of securities - PCK 19 Sep 2023 5:27PM $0.029 $0.078 risen by 168.97%
$16 Investor Presentation 14 Sep 2023 9:59AM $0.028 $0.078 risen by 178.57%
$16 Proposed issue of securities - PCK 14 Sep 2023 9:57AM $0.028 $0.078 risen by 178.57%
$16 PainChek A$3.55m Placement 14 Sep 2023 9:53AM $0.028 $0.078 risen by 178.57%
$16 Trading Halt 12 Sep 2023 9:18AM $0.028 $0.078 risen by 178.57%
$16 Preliminary Final Report 31 Aug 2023 9:20AM $0.030 $0.078 risen by 160%
$16 US nursing home study to pave way for FDA De Novo clearance 24 Aug 2023 11:17AM $0.029 $0.078 risen by 168.97%
$16 Investor Presentation Webinar 27 Jul 2023 9:59AM $0.028 $0.078 risen by 178.57%
$16 Quarterly Update and Appendix 4C 26 Jul 2023 8:49AM $0.028 $0.078 risen by 178.57%
$16 Investor Presentation Webinar 25 Jul 2023 1:53PM $0.029 $0.078 risen by 168.97%
$16 PainChek receives $1.049m R&D Tax Incentive Refund 25 Jul 2023 8:55AM $0.028 $0.078 risen by 178.57%
$16 Ethos Laboratories Distribution Agreement 15 Jun 2023 10:52AM $0.026 $0.078 risen by 200%
$16 Investor Presentation Webinar 2 May 2023 8:31AM $0.028 $0.078 risen by 178.57%
$16 Quarterly Investor Webinar - Tuesday 2 May 28 Apr 2023 4:30PM $0.027 $0.078 risen by 188.89%
$16 Quarterly Update and Appendix 4C 28 Apr 2023 3:25PM $0.027 $0.078 risen by 188.89%
$16 PainChek to Present at NWR Virtual Healthcare Conference 15 Mar 2023 5:10PM $0.026 $0.078 risen by 200%
$16 Change of Director's Interest Notices x 5 9 Mar 2023 12:38PM $0.026 $0.078 risen by 200%
$16 Notification of cessation of securities - PCK 9 Mar 2023 12:12PM $0.026 $0.078 risen by 200%

201 - 225 of 485 results

Page 9 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.